Equipotent Activity in Both Enantiomers of a Series of Ketopiperazine-Based Renin Inhibitors
Powell, N.A., Clay, E.H., Holsworth, D.D., Bryant, J.W., Ryan, J.M., Jalaie, M., Zhang, E., Edmunds, J.J.(2005) Bioorg Med Chem Lett 15: 2371
- PubMed: 15837327 
- DOI: https://doi.org/10.1016/j.bmcl.2005.02.085
- Primary Citation of Related Structures:  
2BKS, 2BKT - PubMed Abstract: 
We have found that both enantiomeric configurations of the 6-alkoxymethyl-1-aryl-2-piperazinone scaffold display equipotent renin inhibition activity and similar SAR patterns. This enantiomeric flexibility is in contrast to a previously reported 3-alkoxymethyl-4-arylpiperidine scaffold.
Organizational Affiliation: 
Pfizer Global Research and Development, Michigan Laboratories, Ann Arbor, MI 48105, USA. noel.powell@pfizer.com